Unknown NA INTERVENTIONAL 2-arm NCT05445024

Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients

Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients After Laparoscopic Gastrointestinal Surgery: A Double-blind, Randomized, Controlled Clinical Study

Sponsor: Qianfoshan Hospital

Conditions Gastrointestinal Surgery Laparoscopic

Interventions nalbuphine group sufentanil group

Updated 5 times since 2022 Last updated: Apr 2, 2023 Started: Jan 1, 2023 Primary completion: Nov 30, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Gastrointestinal Surgery and Laparoscopic and is currently ongoing. Qianfoshan Hospital leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

May 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2022 — May 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Qianfoshan Hospital

Data source: Qianfoshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinan, China